← All chemicals

CAS 95-54-5

1,2-Phenylenediamine

aromatic diaminedye intermediateHAPprobable carcinogen

1,2-Phenylenediamine (o-phenylenediamine) is a versatile aromatic diamine used to manufacture corrosion inhibitors, antioxidants, and dyes — with a carcinogenicity classification and skin sensitizing properties that require careful occupational controls.

Where It Comes From

o-Phenylenediamine was first synthesized in the late 19th century through reduction of o-dinitrobenzene and found broad application as a chemical intermediate. [1] It is used to synthesize benzimidazole heterocycles (including antifungal and antiparasitic drugs), rubber antioxidants, corrosion inhibitors for metals and industrial fluids, and dye intermediates. Annual production in the United States has historically been in the range of millions of pounds. NTP carcinogenicity bioassays conducted in the 1980s found increased incidence of liver tumors in rodents, supporting its classification as a probable human carcinogen by the EPA. [2] The carcinogenic mechanism is thought to involve metabolic activation of the diamine moiety to reactive electrophilic intermediates that form DNA adducts in hepatic tissue. o-Phenylenediamine is listed as a Hazardous Air Pollutant and appears on the TRI. It is released from chemical manufacturing facilities producing rubber chemicals, corrosion inhibitors, and pharmaceutical intermediates. [3] Less industrially significant than its para isomer (p-phenylenediamine, which is the active ingredient in most permanent hair dyes), o-phenylenediamine nonetheless presents similar mechanistic concerns regarding aromatic amine carcinogenesis.

How You Are Exposed

Occupational exposure in chemical synthesis facilities handling the compound as a raw material or intermediate is the primary pathway. Workers in rubber chemical production and metalworking fluid formulation may also encounter it. Skin absorption during handling is significant for amine compounds. The general public has minimal direct exposure; trace environmental releases from industrial facilities contribute very small background exposures.

Why It Matters

The probable carcinogen classification based on hepatic tumors in animals reflects the general aromatic amine carcinogenesis pathway — metabolic N-hydroxylation to reactive species capable of DNA adduct formation. Acute toxicity includes skin and eye irritation, methemoglobin formation at higher doses, and skin sensitization. [2] Workers who develop sensitization will react to future exposures even at low concentrations. The combination of sensitization potential and carcinogen classification warrants stringent exposure controls.

Who Is at Risk

Chemical plant workers synthesizing or handling o-phenylenediamine, rubber chemical industry workers, and pharmaceutical synthesis workers are at greatest risk. Laboratory chemists using it as a reagent for analytical chemistry applications (it is used in colorimetric assays) face lower but not negligible exposures.

How to Lower Your Exposure

1. Use closed synthesis systems and local exhaust ventilation in manufacturing settings. 2. Wear nitrile or neoprene gloves and eye protection; avoid skin contact, as dermal absorption is significant. 3. Biological monitoring (urinary aromatic amine metabolites) should be part of occupational health programs. 4. Explore substitution with less toxic intermediates where the chemistry allows. 5. Annual urinalysis for workers with significant historical exposure to screen for early signs of organ effects.

References

  1. [1][1] Ullmann's Encyclopedia of Industrial Chemistry. Phenylenediamines. Wiley-VCH.
  2. [2][2] US EPA IRIS. o-Phenylenediamine (CASRN 95-54-5). https://cfpub.epa.gov/ncea/iris/iris_documents/documents/subst/0297_summary.pdf
  3. [3][3] NTP Technical Report 351 (1989). Toxicology and Carcinogenesis Studies of 1,2-Phenylenediamine Dihydrochloride.

Recovery & Clinical Information

Body Half-Life

o-Phenylenediamine follows the typical aromatic amine metabolic fate: hepatic N-acetylation and N-hydroxylation, with urinary excretion of conjugated metabolites within 24–48 hours. Acetylator phenotype (fast vs. slow) may influence the balance of detoxification versus bioactivation pathways, as with other arylamines.

Testing & Biomarkers

No routine clinical biomarker test. Research methods detect o-phenylenediamine and its metabolites (acetyl derivatives, hydroxylated products) by LC-MS/MS. Patch testing is available for assessing sensitization. Liver function tests and methemoglobin measurement are appropriate for acute high-dose or chronic occupational exposures.

Interventions

Remove from exposure source. Skin contact: wash with soap and water. For sensitization: strict avoidance of further contact; treat active dermatitis with topical corticosteroids. No specific antidote for systemic toxicity. Methylene blue for significant methemoglobinemia. Long-term: liver function surveillance for heavily exposed workers.

Recovery Timeline

Metabolites clear within 48 hours of last exposure. Skin sensitization is permanent. Cancer risk from past exposure remains but does not increase after ending exposure.

Recovery References

  1. [1]US EPA IRIS. o-Phenylenediamine. https://cfpub.epa.gov/ncea/iris/iris_documents/documents/subst/0297_summary.pdf
  2. [2]IARC Monographs Vol. 16 (1978). Some Aromatic Amines and Related Nitro Compounds. o-Phenylenediamine, pp. 111–130.

Track your exposure to 1,2-Phenylenediamine

Pollution Profile maps your lifetime exposure history to EPA-tracked chemicals.

Get early access

We use cookies and analytics to understand how people use Pollution Profile and improve the experience. We never sell your data. Learn more.